Anticoagulant therapy for central retinal vein occlusion Iseko Nomatsu 1 , Fumiyo Kawamura 1 , Osamu Maki 1,2 1Department of Ophthalmology, Ebara Metropolitan Hospital 2St. Marianna University School of Medicine pp.1105-1109
Published Date 1980/7/15
DOI https://doi.org/10.11477/mf.1410208163
  • Abstract
  • Look Inside

Four cases with impending central retinal vein occlusion were treated by systemic anticoagulant therapy. Usually, warfarin sodium was given at the daily dosis of 2 to 3mg. The maintenance dosis was determined by thrombotest values which was to be kept between 10 and 30%. Striking improvement of fundus findings occurred in 2 to 3 weeks accom-panied by significant improvements in visual acuity. No side effects, including hemorrhage from the urinary tract, were encountered throughout the cases.

Copyright © 1980, Igaku-Shoin Ltd. All rights reserved.


電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院